AFFiRiS will explore ProBioGen's Human Artificial Lymph Node Technology for Vaccine Testing
AFFiRiS AG will explore ProBioGen's proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for it…
AFFiRiS AG will explore ProBioGen's proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for it…